ArticleCase reports in psychiatry2021

Plasmapheresis, Rituximab, and Ceftriaxone Provided Lasting Improvement for a 27-Year-Old Adult Male with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS).

Adam Krouse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.